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Abstract
Background—Asthma severity is a key indicator to assess asthma care and management. 
Severity status may vary over time. Assessing asthma severity periodically is important for 
monitoring the health and well-being of people with asthma.
Objective—To assess population-based asthma severity and to identify related-risk factors 
among children and adults with asthma.
Methods—We used the 2006–2010 BRFSS child and adult Asthma Call-back Survey. Asthma 
severity was classified as intermittent or persistent. We performed multivariate logistic regression 
to identify related-risk factors.
Results—Overall, 63.8% of persons with asthma had persistent asthma. Persistent asthma was 
more prevalent among children aged 0–4 years (71.8%; prevalence rate ratio [PR] = 1.3). Among 
adults with current asthma, persistent asthma was more prevalent among those who were 45 years 
or older (aged 45–54: 69.4%; PR = 1.1, aged 55–64: 72.6%; PR = 1.2, and aged 65+: 77.8%; PR = 
1.3); annual household incomes of <$15 000 (74.1%; PR = 1.1); and first diagnosed at age 55 
years or older (first diagnosed at age 55–64: 80.4%; PR = 1.1, at age 65 + : 81.5%; PR = 1.1). The 
prevalence of persistent asthma was also higher among current smokers who were also exposed to 
secondhand smoke (SHS) (74.7%; PR = 1.1); and among those with Chronic Obstructive 
Pulmonary Disease (COPD) (77.1%; PR = 1.2).
Conclusions—Nearly two-thirds of children and adults with asthma had persistent asthma. 
Identifying related-risk factors could help improve targeted interventions or strategies to reduce 
modifiable predictors (low income, smoking, and SHS) of increased asthma severity. Such 
strategies could improve asthma care and quality of life.
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Asthma is a chronic lung disease that inflames and narrows the airways. Asthma affects 
nearly 26 million people, including 7.0 million children [1] who may experience recurring 
episodes of wheezing, chest tightness, shortness of breath, and coughing. These recurring 
episodes cause sleeplessness, daytime fatigue, reduced activity levels, school and work 
absenteeism, and increased health care use [1,2]. These, in turn, increase the economic 
burden on patients and society [3]. Although asthma cannot be cured, with effective asthma 
care and management, most persons with asthma can be free of symptoms and have a better 
quality of life. One of the key components of effective asthma care and management is 
assessing asthma severity to select appropriate therapy and to monitor the health and well-
being of people with asthma [4,5].
Although the causes of asthma and the determinants of asthma severity remain poorly 
understood, multiple environmental and genetic factors play an important role in the 
development of asthma and the exacerbation of asthma symptoms [6–8]. Asthma severity is 
the inherent intensity of the disease process while asthma control refers to the degree that 
symptoms are successfully managed. Disease progression and symptoms can vary among 
individuals and within an individual’s experience over time. Although we do not know the 
factors that determine these variations and the underlying asthma severity, knowing asthma 
severity status is important to determining the type of treatment, its duration, and its effects 
on the level of asthma control that minimizes the frequency and intensity of symptoms and 
functional limitations [4,5].
Assessing the health and economic burden of the disease requires that one take both asthma 
severity and control into account. Several population-based studies have assessed the level 
of asthma control and examined the factors associated with asthma control [9–12]. However, 
to the best of our knowledge, limited population-based studies attempt to assess asthma 
severity [13,14]. One major issue in classifying asthma severity after treatment has started is 
that the severity of disease is most accurately assessed in patients before the initiation of 
long-term control medication and once a therapy has been started, the focus is on monitoring 
the level of control, not the level of severity [4]. Many respondents are already receiving 
long-term control medication at the time of the survey, further complicating the 
classification of asthma severity. Other issues impeding the population-based assessment of 
asthma severity is the varying measures used to classify severity, and the confusion between 
the underlying severity of disease and the current level of symptom control [15,16].
To evaluate population-based asthma severity, Fuhlbrigge and colleagues [13] defined 
asthma severity using the NAEPP 2003 guidelines. They showed that 77.3% of the study 
population (both children and adults with asthma) had moderate to severe persistent asthma. 
Colice and colleagues [14] used the NAEPP 2007 guidelines (EPR-3) to define asthma 
severity by using measures for current impairments and risk for future exacerbations among 
adolescents (aged 12–17 years) and adults (aged ≥18 years). They showed that 79% of 
patients had persistent asthma. For this study, we used the NAEPP 2007 guidelines for 
asthma severity classification for clinical research and population-based evaluations—that 
is, severity can be inferred from the least amount of treatment required to maintain asthma 
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control [4]. We assessed asthma severity and determined the factors associated with it 
among children and adults with asthma in the states that participated in the Centers for 
Disease Control and Prevention’s Behavioral Risk Factor Surveillance System (BRFSS) 
Asthma Call-back Survey (ACBS).
Methods
Survey data description
We analyzed 2006–2010 data from the BRFSS Asthma Call-back Survey (ACBS) for 
children (aged 0–17 years) and adults (aged 18 years and older). We combined 5 years of 
survey data to provide more stable estimates. During the 2006–2010 survey years, 35 states 
and the District of Columbia participated in the Child ACBS, while 40 states and the District 
of Columbia participated in the Adult ACBS.
The BRFSS ACBS is developed and funded by the Air Pollution and Respiratory Health 
Branch (APRHB) in the National Center for Environmental Health (NCEH), Centers for 
Disease Control and Prevention (CDC). It has been implemented as a follow-up survey to 
the BRFSS since 2006. The BRFSS ACBS is conducted approximately 2 weeks after the 
BRFSS telephone interview. Although BRFSS is a state-based, random-digit-dialed 
telephone survey of non-institutionalized U.S. adults, the BRFSS survey contains a Random 
Child Selection module and a Child Asthma Prevalence module, both of which were used in 
participating states to identify households with a child who had asthma in order to 
administer the Child ACBS. BRFSS respondents who report ever being diagnosed with 
asthma are eligible for the ACBS. Only one adult or one child per household could 
participate in the ACBS. An adult family member served as a proxy respondent for the child. 
The ACBS collects in-depth information about asthma symptoms and episodes/attacks, self-
management education, healthcare utilization and access, medication use, comorbidities, and 
environmental allergens and irritants [17]. The ACBS response rate for children and adults 
varies by state and year. The median ACBS response rates for children (via adult proxies) 
ranged from 47.6% to 53.7% and for adults ranged from 47.5% to 54.3% during 2006–2010. 
More information on participating states, weight calculation, and the response rate can be 
found in the ACBS Summary Data Quality Report for each year at http://www.cdc.gov/
brfss/acbs [17]. The data include sample weights to adjust for the unequal probability of 
selection, the disproportionate selection of population subgroups relative to the state’s 
population distribution, and disproportionate non-response.
Variables
We evaluated asthma severity status among children and adults with current asthma. 
Consistent with the methodology used with previous CDC publications, respondents were 
considered to have current asthma if they answered “yes” to both questions “Have you ever 
been told by a doctor, nurse, or other health professional that you had asthma?” and “Do you 
still have asthma?” [1,2].
Asthma severity was classified according to the severity classification for clinical research 
and population-based evaluations that was stated in EPR-3 [4]. Severity was inferred from 
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the least amount of treatment required to maintain control. This way of defining severity 
depends on whether a respondent is receiving treatment and how well that treatment 
achieves a satisfactory level of control. To classify asthma severity, we first classified 
respondents as well controlled, not well controlled, and very poorly controlled using three 
impairment measures: daytime symptoms during the past 30 d, nighttime symptoms during 
the past 30 d, and use of short-acting β2-agonists (SABA) during the past 3 months for 
symptom control (not for prevention of exercise-induced bronchospasm) (Table 1). This is a 
modified version of the 2007 NAEEP guidelines because the ACBS did not include all 
required measures for current impairment (e.g. pulmonary function measures) and for future 
risk assessment (e.g. asthma exacerbations, progressive decline in lung function in adults, or 
reduced lung growth in children). We did not include one of the impairment measures, 
interference with normal activities, because the reference time for the question was the past 
12 months and should only include more recent experiences [18]. Long-term asthma control 
medications (e.g. inhaled corticosteroids, systemic corticosteroids, long-acting beta2 agonist, 
Leukotriene receptor antagonists, methylxanthines, and immunomodulators) are used daily 
on a long-term basis to achieve and maintain control of persistent asthma [4]. Using asthma 
control status and long-term control medication status, we classified asthma severity into 
two categories: intermittent and persistent. Intermittent asthma includes those with current 
asthma whose asthma is well-controlled without being on long-term control medications. 
Persistent asthma includes those on long-term control medications, regardless of asthma 
control status, and those not on long-term control medications whose asthma is not well 
controlled or is very poorly controlled (Table 2). We did not sub-categorize persistent 
asthma as mild, moderate, or severe to avoid misclassification because of the absence of 
detailed information on long-term control medication use in the data.
In addition, for both children and adults, variables for demographic characteristics (age, sex, 
race/ethnicity), annual household income, age at the time asthma was first diagnosed, time 
since asthma was diagnosed, and environmental factors (secondhand smoking, pets allowed 
in bedroom, saw cockroach inside home in past 30 d, and saw or smelled mold in the past 30 
d) were included in the analysis. For adults only, body mass index (BMI) (defined as weight 
in kilograms divided by height in square meters; obese = BMI ≥ 30), the presence of chronic 
obstructive pulmonary disease (COPD), depression, and smoking status were also included 
in the analysis. Depression variable includes responses to the question: “ever been told by a 
doctor or other professional that you were depressed?” and the COPD variable includes 
responses to the questions: “ever been told by a doctor or other professional that you have 
emphysema,” “ever been told by a doctor or other professional that you have COPD,” or 
“ever been told by a doctor or other professional that you have chronic bronchitis.”
Statistical analysis
We used SAS-callable SUDAAN (version 10.0.0, RTI International, NC) to account for the 
complex sampling design of the BRFSS ACBS. Data from the participating states for each 
year were reweighted to account for the differences in sample size by year. We used sample 
weights to produce estimates that were generalizable to a participating state’s population. In 
addition to calculating descriptive statistics, we used the chi-square test and multivariate 
logistic regression to test for group differences and association between persistent asthma 
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status and independent variables of interest. We presented weighted percent estimates, 
adjusted prevalence ratios (aPR) (predicted marginal risk ratio), and 95% confidence 
intervals (CI). All prevalence ratios for both children and adults were adjusted (aPR) for sex, 
age, annual household income, age at first asthma diagnosis, time since asthma diagnosis, 
and environmental factors. In addition, prevalence ratios for adults were also adjusted for 
BMI, COPD, and depression. We did not find any multi-collinearity between independent 
variables since all tolerance estimates were ≥0.73, and only tolerance estimates below 0.40 
are a concern [19]. Statistical significance was determined as a p value<0.05 by a non-
directional z-test or by non-overlapping 95% CIs. Relative standard error (RSE = standard 
error/prevalence estimate) was used as a measure of an estimate’s reliability (a RSE of <0.30 
indicates a “reliable” estimate) [20].
Results
All persons with current asthma
Overall, 63.8% of persons with current asthma had persistent asthma, 36.2% had 
intermittent asthma, 42.5% were on long-term control medication, and 47.5% had 
uncontrolled asthma.
Children with current asthma
Characteristics—In the combined 2006 through 2010 BRFSS ACBS sample, 9697 
children met the definition of current asthma and were included in this analysis. Of children 
with current asthma, 60.3% met the definition for persistent asthma and 39.7% for 
intermittent asthma. Forty-six percent of children with current asthma were on long-term 
control medications and 38.4% had uncontrolled asthma (either not well controlled or very 
poorly controlled asthma) (Table 3).
Most of the children with current asthma were non-Hispanic white (57%) and male (57%). 
By age, 18.3% of children with asthma were aged 0–4 years, 43% were aged 5–11 years and 
38% were aged 12–17 years. More than 50% of the children with asthma were in homes 
with annual household income of $50 000 or more. More than 65% had their asthma initially 
diagnosed when they were between ages 0 and 4 years. About 10% had been diagnosed with 
asthma within the past 12 months, and 41% were diagnosed 1–5 years ago, while 48% were 
diagnosed more than 5 years ago. The birth weight of most children with asthma was 2500 g 
or more (not low birth weight). Sixty-six percent had pets, and for 33% of the children, the 
pet was allowed in the child’s bedroom. Between 8% and 10% of the children with asthma 
were exposed to secondhand smoke (SHS) (9.9%), lived where a cockroach was seen 
(8.0%), or where mold was seen or smelled inside the home in the past 30 d (9.0%) (Table 
4).
Asthma severity and related risk factors among children with asthma—
Persistent asthma prevalence was significantly higher among children with asthma aged 0–4 
years (71.8%; aPR = 1.3[1.1–1.5]) than among those aged 12–17 years (52.9%), and was 
significantly lower among members of other races (49.0%; aPR = 0.8[0.6–0.9]) than among 
whites (61.3%). Unadjusted persistent asthma prevalence was also significantly higher 
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among those who had been diagnosed with asthma at 0–4 years of age (63.9%) than among 
those who had been diagnosed at 12–17 years of age (47.1%). It was also higher if the time 
since asthma was first diagnosed was within the past 12 months (73.8%) than if it was 
diagnosed more than 5 years ago (57.8%); however, after adjustment for other variables in 
the model, these associations were no longer statistically significant. Regardless of 
adjustment, no association was observed with sex, household income, birth weight, and all 
environmental factors (SHS, saw cockroach inside home in past 30 d, or saw or smelled 
mold in past 30 d) (Table 4).
Adults with current asthma
Characteristics—In the combined 2006 through 2010 BRFSS ACBS sample 52210 adults 
classified as having current asthma were included in this analysis. Of adults with current 
asthma, 64.8% met the definition of persistent asthma and 35.2% met the definition of 
intermittent asthma. About 41% of adults with current asthma were on long-term control 
medications and 50% had uncontrolled asthma (either not well controlled or very poorly 
controlled asthma) (Table 3).
The majority of adults with current asthma were non-Hispanic whites (74.6%), and female 
(63.1%). About 31% of adults with current asthma were aged 18–34 years, 18.5% were aged 
35–44 years, 19.6% were aged 45–54 years, 15.9% were aged 55–64, and 15.3% were aged 
65+ years. Nearly 45% of adults with asthma had annual household incomes of $50 000 or 
more. Forty-five percent had child-onset asthma and 55% had adult-onset asthma. Most of 
the adults with current asthma were diagnosed more than 5 years ago (85.7%). Thirty-nine 
percent were obese. About 50.4% were smokers (current or former) or exposed to SHS. 
One-third had COPD (34.6%) and 34.7% had depression. Sixty percent had pets, and 44% 
of adults with asthma allowed the pets in their bedroom. About 10% saw a cockroach inside 
the home in the past 30 d (9.7%) or saw/smelled mold in the past 30 d (11.6%) (Table 5).
Asthma severity and related risk factors among adults with current asthma—
Persistent asthma prevalence was significantly higher among adults with current asthma who 
were 45 years or older (45–54: 69.4%; aPR = 1.1[1.1–1.2]; 55–64: 72.6%; aPR = 1.2[1.1–
1.2]; 65 + : 77.8%; aPR = 1.3[1.2–1.3]) than among those aged 18–34 years (53.4%). 
Persistent asthma prevalence was higher among adults with household income less than $15 
000 (74.1%; aPR = 1.1[1.1–1.2]) than among those with income of $75 000 or more 
(58.1%). Persistent asthma prevalence was higher for those with older age at first diagnosis. 
Rates were significantly higher for those with an age at first diagnosed of 55–64 (80.4%; 
aPR = 1.1[1.1–1.2]) and 65+: 81.5%; aPR = 1.1[1.1–1.2]. In contrast, persistent asthma 
prevalence for those diagnosed at age 18–24 years was 63.2%. Also significantly associated 
with higher rates of persistent asthma were having COPD (77.1%; aPR = 1.2[1.1–1.2]) and 
smokers who were also exposed to SHS (74.7%; aPR = 1.1[1.1–1.2]). The corresponding 
reference levels were 58.4% and 60.1% respectively. Unadjusted persistent asthma 
prevalence was significantly higher among females (66.3%) than among males (62.2%) and 
among adults whose time since asthma diagnosis was within the past 12 months (75.5%) 
than if initial diagnosis was more than 5 years ago (64.1%). The unadjusted persistent 
asthma prevalence was higher among the obese (68.4%) than among the non-obese (62.3%) 
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and it was higher among those who were depressed (70.5%) than among those who were not 
(62.0%). However, after adjustment for other variables in the model, the associations with 
sex, time since diagnosis, obesity, and depression were no longer statistically significant. 
Regardless of adjustment, neither race/ethnicity nor any of the environmental factors (pets 
allowed in bedroom, saw cockroach inside home in past 30 d, or saw or smelled mold in past 
30 d) were associated with persistent asthma status (Table 5).
Discussion
The purpose of this population-based study was to assess asthma severity and identify 
related potential risk factors among children and adults with current asthma who participated 
in the ACBS in the years 2006 through 2010. Similar to the findings of previous studies 
[13,14], persistent asthma prevalence was high among this study population (63.8%); the 
rate was 60.3% among children and 64.8% among adults with current asthma. However, the 
rate was not as high as that reported by Fuhlbrigge et al. 2002 (77.3%) [13] and Colice et al. 
2012 (79%) [14]. The difference in the rates reported by those studies could be attributable 
to differences in study methods and the population characteristics. In addition, our analysis 
finds that 42.5% of those with current asthma were on long-term control medications (higher 
for children [46%] than adults [41%]), and 47.5% had uncontrolled asthma (higher for adults 
[50.0%] than children [38.4%]).
Multiple extraneous factors (e.g. inadequate treatment, non-adherence to treatment 
regimens, reduced responsiveness to therapy, uncontrolled environmental triggers and 
irritants, and comorbid conditions) could contribute to these findings [6,9,21–25]. However, 
many of these factors were either not examined because of a lack of data or else examined 
but did not show an association. In this study, we were able to identify some of the 
predictors of persistent asthma. Age was a strong predictor of asthma severity for both 
children and adults. Persistent asthma was more prevalent among children aged 0–4 years 
and among adults aged 45 years or older. Children, especially preschoolers, are at greater 
risk of developing illness because of developing immune system, hand-to-mouth behavior, 
lower body weight and higher intake rate, resulting in a greater dose of hazardous substance 
per unit of body weight, and dependence on others to meet basic needs such as housing, 
medical care and protection from hazardous environmental conditions [26]. These 
characteristics make children prone to frequent upper respiratory infections (common cold, 
ear infections, and epiglottitis) and make them susceptible to environmental allergens and 
irritants that may lead to exacerbation of asthma symptoms [24,26]. Although we did not 
observe the association, asthma duration (time since diagnosed) is associated with having 
persistent asthma (lower lung function, greater airway responsiveness, more asthma 
symptoms, and greater use of quick-relief asthma medications) among children [27,29].
As with previous studies [21,22,25,28,29], our study indicates that factors associated with 
persistent asthma among adults were being 45 years or older, having a household income of 
less than $15 000, older age at first diagnosis (aged 55 years or older), smoking and also 
exposure to SHS, and having COPD. However, for both children and adults, none of the 
known environmental risk factors for symptom exacerbations (cockroaches, mold, pets, and 
SHS [children only]) were significantly associated with persistent asthma [5,6]. Ours is not 
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an unusual result, since a study of the same population at different time periods or a study of 
different populations can produce different results [30] and also because of social 
desirability bias associated with self-report surveys that is over-reporting desirable behaviors 
(exercise, not smoking) or under-reporting less desirable behaviors (smoking, mold, and 
cockroaches) [31]. Additional studies can be helpful in identifying additional modifiable 
predictors of uncontrolled asthma and determining contributing factors for persistent asthma. 
These efforts can lead to developing targeted interventions, producing strategies that reduce 
the health risks and economic impact of asthma and improving the health and well-being of 
people with asthma.
The strength of this study is that we analyzed a large sample size of children and adults with 
current asthma and assessed asthma severity status and symptom control in states that 
participated in the ACBS; the ACBS is the only survey providing most of the indicators that 
allow classification of asthma severity and asthma control by use of the NAEPP guidelines 
(EPR-3) and can be used to evaluate population-based asthma severity and symptom control.
There are also limitations to our study. One limitation is that the indicators available in the 
ACBS which can be used to classify asthma control and severity circumscribed our findings. 
Because of the content of the ACBS questionnaire, we were unable to include all of the 
required elements in the NAEPP guidelines (e.g. activity limitation, pulmonary function 
measures, asthma exacerbations that require oral corticosteroid and lung growth status in 
children) [4]. This limitation may lead to underestimation of persistence asthma prevalence. 
However, the definition of asthma control and severity in this analysis is consistent with the 
definition in other reports of population-based estimates [9,13,14]. Another limitation is that 
the ACBS response rates for the participating states were around 50%. Low response rates 
may affect the results by introducing non-response bias, if survey respondents differed from 
non-responders on the characteristics studied. However, the BRFSS sampling procedures 
and varying response rates among states over the 5-year study period can minimize non-
response effects on the results [20,30]. In addition, because of the cross-sectional nature of 
the survey data, we could not generally determine the temporal sequence or causality. 
Finally, the findings cannot be generalized to the people with current asthma in states that 
did not participate in the ACBS.
Conclusion
Our findings indicate that nearly two-third of children and adults with current asthma had 
persistent asthma. Moreover, despite national guidelines for asthma control and available 
advanced medical treatments, 38% of children and 50% of adults had uncontrolled asthma. 
Age (being aged 0–4 or 45 years or older), having a household income of less than $15 000, 
the age at which asthma is initially diagnosed (if aged 55 years or older), smoking and 
exposure to SHS, and COPD were significantly associated with having persistent asthma. 
There is a need for further studies to identify additional modifiable contributing factors for 
persistent asthma, because asthma severity determines the level of asthma control and 
responsiveness to therapy. Such additional studies can lead to development of targeted 
interventions or strategies that will reduce modifiable predictors of increased asthma 
severity and poor asthma control and, in turn, improve asthma care and quality of life.
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Table 1
Classification of asthma control modified from the National Asthma Education and Prevention Program 
Expert Panel Report 3 guidelines.
Measures for current impairment Well controlled Not well controlled Very poorly controlled
Symptoms ≤2 d/week >2 d/week Throughout the day
Nighttime awakenings ≤1×/month (aged 0–4 yrs)
≤1×/month (aged 5–11 yrs)
≤2×/month (aged ≥12 yrs)
>1×/month (aged 0–4 yrs)
≥2×/month (aged 5–11 yrs)
1–3×/week (aged ≥12 yrs)
>1×/week (aged 0–4 yrs)
≥2×/week (aged 5–11 yrs)
≥4×/week (aged ≥12 yrs)
Short-acting β2-agonists used
 for symptom control
≤2 d/week >2 d/week   Several times/day
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Table 2
Classification of asthma severity for research and population-based estimates from the National Asthma 




medication use Asthma control status
Intermittent asthma No • Well controlled
Persistent asthma Yes • Well controlled,
• Not well controlled, or
• Very poorly controlled asthma
No • Not well controlled or
• Very poorly controlled asthma
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Table 3
Asthma severity, long-term control medication, and uncontrolled asthma status among children and adults 




(aged 0–17 years) (n=9697)
Adults with asthma
(aged 18 years or older) (n=52 210)
% (95% CIb) Sample sizec % (95% CIb) Sample sizec % (95% CIb)
Asthma severity status
Intermittent Asthma 36.2 (35.2–37.1) 4013 39.7 (37.4–41.9) 15 680 35.2 (34.1–36.2)
Persistent Asthma 63.8 (62.9–64.8) 5684 60.3 (58.1–62.6) 36 530 64.8 (63.8–65.9)
Long-term control medication 42.5 (41.6–43.4) 4332 46.0 (43.7–48.3) 24 786 41.5 (40.5–42.5)
Uncontrolled asthma (Not well- or
 very poorly controlled asthma)
47.5 (46.6–48.5) 3518 38.4 (36.2–40.8) 27 832 50.0 (49.0–51.1)
Data source: CDC/BRFSS. Behavioral Risk Factor Surveillance System: Child and Adult Asthma Call-Back Survey, 2006–2010.
a
Includes persons who answered “yes” to the questions: “Have you ever been told by a doctor, nurse, or other health professional that you had 
asthma?” and “Do you still have asthma?”
b
Weighted and unadjusted percentage and 95% confidence interval.
c
Unweighted pooled sample size, 2006–2010. Due to item non-response, individual characteristic categories may not sum to total.
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Table 4
Asthma severity status among children (aged 0–17 years) with current asthmaa: Behavioral Risk Factor 
Surveillance System Asthma Call-back Survey, 2006–2010.
Survey respondents





Characteristics Sample sizeb % (95% CIc) % (95% CIc) aPR
Total 9697 60.3 (58.1–62.6)
Sex p=0.3628
 Male 5536 57.0 (54.7–59.3) 61.2 (58.2–64.1) Referent
 Female 4126 43.0 (40.7–45.4) 59.0 (55.5–62.5) 1.0 (0.9–1.1)
Age, year range p<0.0001
 0–4 1213 18.3 (16.4–20.4) 71.8 (66.3–76.8) 1.3 (1.1–1.5)
 5–11 3746 43.5 (41.2–45.9) 62.1 (58.6–65.4) 1.1 (1.0–1.3)
 12–17 4738 38.2 (36.0–40.4) 52.9 (49.4–56.3) Referent
Race/ethnicityd p=0.0515
 White 6472 57.2 (54.7–59.6) 61.3 (58.7–63.8) Referent
 Black 991 15.9 (14.2–17.9) 62.4 (56.1–68.3) 1.0 (0.9–1.1)
 Hispanic 971 16.9 (15.0–19.1) 63.2 (56.3–69.5) 1.0 (0.9–1.1)
 Other race 904 10.0 (8.5–11.6) 49.0 (40.9–57.1) 0.8 (0.6–0.9)
Household income p=0.6349
 <$15 000 811 11.7 (9.9–13.9) 65.2 (56.9–72.7) 1.1 (0.9–1.2)
 $15 000–$24 999 1223 14.5 (12.9–16.3) 56.7 (50.0–63.2) 0.9 (0.8–1.1)
 $25 000–$49 999 2103 21.0 (19.3–22.9) 60.4 (55.6–64.9) 1.0 (0.9–1.1)
 $50 000–$74 999 1684 16.6 (14.9–18.5) 59.7 (54.0–65.2) 1.0 (0.9–1.1)
 ≥$75 000 3351 36.1 (34.0–38.3) 60.9 (57.3–64.3) Referent
Age at asthma diagnosis p<0.0001
 0–4 5633 65.8 (63.7–67.9) 63.9 (61.1–66.6) 1.2 (1.0–1.5)
 5–11 3120 28.5 (26.5–30.5) 54.7 (50.6–58.7) 1.2 (0.9–1.4)
 12–17 751 5.7 (4.8–6.7) 47.1 (38.5–55.8) Referent
Time since asthma diagnosis p<0.001
 Within the past 12 months 810 9.9 (8.6–11.4) 73.8 (66.5–80.0) 1.2 (1.0–1.4)
 1–5 years ago 3698 41.5 (39.2–43.8) 60.2 (56.5–63.7) 1.0 (0.9–1.1)
 More than 5 years ago 5156 48.6 (46.3–51.0) 57.8 (54.7–61.0) Referent
Birth weight p=0.3099
 Low birth weight (less than 2500 g) 1059 14.0 (12.5–15.7) 57.4 (51.1–63.5) 0.9 (0.8–1.0)
 Not low birth weight 8070 86.0 (84.3–87.5) 60.9 (58.4–63.3) Referent
Secondhand Smoke exposuree p=0.6409
 Yes 877 9.9 (8.3–11.8) 58.5 (49.8–66.8) 1.0 (0.9–1.1)
 No 8796 90.1 (88.2–91.7) 60.6 (58.3–62.9) Referent
Pets allowed in bedroom p=0.0228
 Pets allowed 3754 33.3 (31.2–35.5) 56.1 (52.4–59.8) 0.9 (0.9–1.0)
 Pets NOT allowed 2226 22.7 (20.9–24.7) 63.3 (58.4–67.9) 1.1 (1.0–1.2)
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Survey respondents





Characteristics Sample sizeb % (95% CIc) % (95% CIc) aPR
 No pets 3710 44.0 (41.7–46.3) 62.0 (58.5–65.4) Referent
Saw cockroach inside home past 30 d p=0.5452
 Yes 721 8.0 (6.9–9.3) 62.8 (54.6–70.3) 1.0 (0.9–1.2)
 No 8945 92.0 (90.7–93.1) 60.3 (57.9–62.6) Referent
Saw or smelled mold past 30 d p=0.0293
 Yes 929 9.1 (7.8–10.6) 68.0 (61.2–74.2) 1.1 (1.0–1.3)
 No 8720 90.9 (89.4–92.2) 59.7 (57.3–62.1) Referent
Data source: CDC/BRFSS. Behavioral Risk Factor Surveillance System: Child Asthma Call-Back Survey, 2006–2010.
a
Includes persons who answered “yes” to the questions: “Have you ever been told by a doctor, nurse, or other health professional that you had 
asthma?” and “Do you still have asthma?”
b
Unweighted pooled sample size, 2006–2010. Due to item non-response, individual characteristic categories may not sum to total.
c
Weighted and unadjusted percentage and 95% confidence interval.
d
Race categories “white, non-Hispanic”, “black, non-Hispanic”, include persons who indicated only a single race group. “Other races, non-
Hispanic” includes Asian, American Indian Alaskan Native, Native Hawaiian and Other Pacific Islander, persons reporting more than one race, and 
persons reporting their race as something other than those listed here.
e
Second-hand smoke exposure (SHS) status: includes children whose caregivers answered “yes” to the questions: “In the past week, has anyone 
smoked inside [his/her] home?”
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Table 5
Asthma severity status among adults (aged 18 years or older) with current asthmaa: Behavioral Risk Factor 
Surveillance System Asthma Call-back Survey, 2006–2010.
Survey respondents





Characteristics Sample sizeb %c (95% CIc) %c (95% CIc) aPR
Total 52 210 64.8 (63.8–65.9)
Sex p<0.001
 Male 13 760 36.9 (35.9–38.0) 62.2 (60.2–64.3) Referent
 Female 38 450 63.1 (62.0–64.1) 66.3 (65.2–67.5) 1.0 (1.0–1.1)
Age, year range p<0.0001
 18–34 5617 30.7 (29.5–31.9) 53.4 (50.8–56.0) Referent
 35–44 6821 18.5 (17.8–19.3) 61.4 (59.1–63.7) 1.1 (1.0–1.1)
 45–54 11 416 19.6 (18.9–20.3) 69.4 (67.8–71.0) 1.1 (1.1–1.2)
 55–64 13 509 15.9 (15.4–16.5) 72.6 (71.1–74.1) 1.2 (1.1–1.2)
 65+ 14 643 15.3 (14.8–15.8) 77.8 (76.5–79.1) 1.3 (1.2–1.3)
Race/ethnicityd p=0.2426
 White 42 517 74.6 (73.6–75.6) 65.5 (64.3–66.6) Referent
 Black 3236 9.7 (9.0–10.3) 63.8 (60.1–67.4) 1.0 (0.9–1.1)
 Hispanic 2342 9.0 (8.3–9.7) 61.6 (57.2–65.8) 1.0 (0.9–1.0)
 Other race 3656 6.7 (6.2–7.4) 62.8 (57.8–67.5) 1.0 (0.9–1.0)
Household income p<0.0001
 <$15 000 8146 14.7 (14.0–15.5) 74.1 (71.5–76.5) 1.1 (1.1–1.2)
 $15 000–$24 999 8967 16.7 (15.8–17.5) 69.5 (66.6–72.3) 1.1 (1.0–1.1)
 $25 000–$49 999 12 351 23.8 (23.0–24.7) 65.7 (63.7–67.7) 1.0 (1.0–1.1)
 $50 000–$74 999 7143 15.1 (14.4–15.8) 63.0 (60.4–65.6) 1.0 (1.0–1.1)
 ≥$75 000 10 428 29.7 (28.7–30.7) 58.1 (55.9–60.2) Referent
Age at asthma diagnosis p<0.0001 Not included
 Child-onset asthma 15 033 44.9 (43.8–46.0) 57.5 (55.6–59.3) –
 Adult-onset asthma 34 303 55.1 (54.0–56.2) 71.4 (70.2–72.5) –
Age at asthma diagnosis p<0.0001
 0–4 4262 12.4 (11.7–13.2) 63.8 (60.5–67.0) 1.1 (1.0–1.1)
 5–11 6347 18.8 (17.9–19.8) 55.8 (52.9–58.7) 0.9 (0.9–1.0)
 12–17 4424 13.6 (12.8–14.5) 54.0 (50.5–57.4) 0.9 (0.9–1.0)
 18–24 4329 10.4 (9.8–11.1) 63.2 (59.9–66.3) Referent
 25–34 6915 13.5 (12.8–14.2) 66.1 (63.2–68.9) 1.0 (1.0–1.1)
 35–44 7817 12.7 (12.1–13.3) 72.9 (70.5–75.2) 1.1 (1.0–1.2)
 45–54 7109 9.2 (8.8–9.7) 76.6 (74.6–78.5) 1.1 (1.0–1.2)
 55–64 4849 5.6 (5.3–6.0) 80.4 (78.0–82.6) 1.1 (1.1–1.2)
 65+ 3284 3.7 (3.4–3.9) 81.5 (78.8–83.9) 1.1 (1.1–1.2)
Time since asthma diagnosis p<0.0001
 Within the past 12 months 1471 3.0 (2.7–3.4) 75.5 (69.9–80.4) 1.1 (1.0–1.2)
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Survey respondents





Characteristics Sample sizeb %c (95% CIc) %c (95% CIc) aPR
 1–5 years ago 6088 11.3 (10.6–12.0) 68.0 (64.4–71.3) 1.0 (0.9–1.1)
 More than 5 years ago 44 466 85.7 (84.9–86.4) 64.1 (63.0–65.2) Referent
Body Mass Index (BMI) p<0.0001
 Obese 20 714 39.4 (38.4–40.4) 68.4 (66.7–70.1) 1.1 (1.0–1.1)
 Non-obese 29 539 60.6 (59.6–61.6) 62.3 (61.0–63.7) Referent
Smoking status and SHSe p<0.0001
 Current smoker & SHS 6353 11.9 (11.2–12.6) 74.7 (71.7–77.6) 1.1 (1.1–1.2)
 Current smoker & No SHS 3138 7.6 (7.1–8.2) 65.2 (61.5–68.8) 1.0 (1.0–1.1)
 Former smoker & SHS 1341 2.6 (2.3–2.9) 74.2 (68.6–79.2) 1.1 (1.0–1.2)
 Former smoker & No SHS 16 247 24.6 (23.8–25.4) 69.3 (67.3–71.2) 1.0 (1.0–1.1)
 Non-smoker & SHS 1143 3.8 (3.3–4.3) 61.3 (53.9–68.3) 1.0 (0.9–1.1)
 Non-smoker &No SHS 23 667 49.6 (48.6–50.7) 60.1 (58.6–61.6) Referent
COPDf p<0.0001
 Yes 21 539 34.6 (33.7–35.5) 77.1 (75.6–78.6) 1.2 (1.1–1.2)
 No 30 480 65.4 (64.5–66.4) 58.4 (57.1–59.7) Referent
Depression p<0.0001
 Yes 19 734 34.7 (33.7–35.6) 70.5 (68.9–72.1) 1.1 (1.0–1.1)
 No 32 133 65.3 (64.4–66.3) 62.0 (60.6–63.3) Referent
Pets allowed in bedroom p=0.2233
 Pets allowed 22 711 44.3 (43.3–45.3) 65.6 (64.1–67.1) 1.1 (1.0–1.1)
 Pets NOT allowed 6950 15.2 (14.4–16.0) 65.5 (62.6–68.4) 1.0 (1.0–1.1)
 No pets 22 542 40.5 (39.5–41.5) 63.7 (62.1–65.3) Referent
Saw cockroach inside home past 30 d p=0.4950
 Yes 4098 9.7 (9.1–10.3) 66.0 (62.5–69.4) 1.0 (0.9–1.1)
 No 47 972 90.3 (89.7–90.9) 64.8 (63.7–65.8) Referent
Saw or smelled mold past 30 d p<0.01
 Yes 6017 11.6 (11.0–12.2) 69.1 (66.2–71.8) 1.1 (1.0–1.1)
 No 45 844 88.4 (87.8–89.0) 64.3 (63.2–65.4) Referent
Data source: CDC/BRFSS. Behavioral Risk Factor Surveillance System: Child Asthma Call-Back Survey, 2006–2010.
a
Includes persons who answered “yes” to the questions: “Have you ever been told by a doctor, nurse, or other health professional that you had 
asthma?” and “Do you still have asthma?”
b
Unweighted pooled sample size, 2006–2010. Due to item non-response, individual characteristic categories may not sum to total.
c
Weighted and unadjusted percent and 95% confidence interval.
d
Race categories “white, non-Hispanic”, “black, non-Hispanic”, include persons who indicated only a single race group. “Other races, non-
Hispanic” includes Asian, American Indian Alaskan Native, Native Hawaiian and Other Pacific Islander, persons reporting more than one race, and 
persons reporting their race as something other than those listed here.
e
Includes adults who smoke and answered “yes” to the questions: “In the past week, has anyone smoked inside your home [secondhand smoke 
exposure (SHS)]?”.
f
Includes adults with emphysema or chronic bronchitis.
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